Bio-Gate AG
Develops antimicrobial & antiviral tech for medical, cosmetic, & industrial products.
BIG1 | F
Overview
Corporate Details
- ISIN(s):
- DE000BGAG981
- LEI:
- 391200G5LKTIOTZOXP90
- Country:
- Germany
- Address:
- Neumeyerstr. 28-34, 90411 Nürnberg
- Website:
- https://www.bio-gate.de/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bio-Gate AG is a leading provider of innovative technologies and customized solutions for health and hygiene. The company specializes in developing and applying antimicrobial and antiviral strategies to enhance materials and products. Its core markets include medical technology, where it provides coatings for medical implants and wound dressings to prevent infections. Bio-Gate's technologies are also utilized in derma-cosmetics, veterinary medicine (featuring its MicroSilver BG™ technology), and a range of industrial and consumer goods such as paints, plastics, and textiles, improving safety and adding value to end products.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bio-Gate AG and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-11 20:04 |
Share Issue/Capital Change
Bio-Gate AG beschliet und platziert Barkapitalerhohung
|
German | 6.1 KB | |
| 2025-08-21 17:58 |
Director's Dealing
Bio-Gate AG: Karl Richter, Zeichnung von Wandelschuldverschreibungen
|
German | 6.0 KB | |
| 2025-08-19 17:50 |
Capital/Financing Update
Bio-Gate AG: Bio-Gate AG beschliet Ausgabe einer Wandelschuldverschreibung unte…
|
German | 6.2 KB | |
| 2025-08-12 17:40 |
Director's Dealing
Bio-Gate AG: Thomas Konradt, Zeichnung von Wandelschuldverschreibungen
|
German | 5.9 KB | |
| 2025-07-31 21:17 |
Earnings Release
Bio-Gate veroffentlicht endgultige Zahlen 2024 und gibt positiven Ausblick fur …
|
German | 13.0 KB | |
| 2025-06-03 21:13 |
Capital/Financing Update
Bio-Gate AG beschliet Ausgabe einer Wandelschuldverschreibung unter Ausschluss …
|
German | 8.4 KB | |
| 2025-04-08 09:56 |
Regulatory News Service
Bio-Gate starkt in Nordamerika Prasenz fur den Absatz von Tierpflegeprodukten f…
|
German | 12.9 KB | |
| 2025-04-08 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 38.0 KB | |
| 2025-02-27 11:09 |
Regulatory News Service
Bio-Gate AG: Medizinisches CBD-Muskelpflege-Gel von Bio-Gate erhalt in klinisch…
|
German | 14.2 KB | |
| 2025-02-26 11:09 |
Earnings Release
Bio-Gate AG: Medizinisches CBD-Muskelpflege-Gel von Bio-Gate erhalt in klinisch…
|
German | 14.2 KB | |
| 2025-02-21 09:30 |
Regulatory News Service
Bio-Gate bringt uber Partner weitere Produktlinie zum Schutz von Haut- und Hufa…
|
German | 13.1 KB | |
| 2025-02-20 09:30 |
Earnings Release
Bio-Gate bringt uber Partner weitere Produktlinie zum Schutz von Haut- und Hufa…
|
German | 13.1 KB | |
| 2025-02-20 09:30 |
Earnings Release
Bio-Gate bringt uber Partner weitere Produktlinie zum Schutz von Haut- und Hufa…
|
German | 13.1 KB | |
| 2024-12-17 09:32 |
Environmental & Social Information
Bio-Gate bietet mit HyProtectTMTechnologie wirksame Infektionspravention in der…
|
German | 15.0 KB | |
| 2024-12-16 09:32 |
Regulatory News Service
Bio-Gate bietet mit HyProtectTMTechnologie wirksame Infektionspravention in der…
|
German | 15.0 KB |
Automate Your Workflow. Get a real-time feed of all Bio-Gate AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Bio-Gate AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
